SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001437749-22-020870
Filing Date
2022-08-18
Accepted
2022-08-18 08:21:40
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 navb20220817_424b3.htm 424B3 83329
2 navb20220817_424b3img001.jpg GRAPHIC 2900
3 navb20220817_424b3img002.jpg GRAPHIC 2900
  Complete submission text file 0001437749-22-020870.txt   92708
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-262691 | Film No.: 221176360
SIC: 2835 In Vitro & In Vivo Diagnostic Substances